EOM Pharmaceutical Holdings, Inc.

IMUC

EOM Pharmaceutical Holdings, Inc.

IMUC

Insider Sentiment (TTM):

Last Purchase:2015-11-30Last Sale:2013-11-26Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2018-09-30Institutional Shares Owned:1,930,912Shares Outstanding:41,913,256Institutional Ownership Pct.:4.61%

Earnings Market Reaction:

Filing Date:N/APrice on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Assets
Cash And Cash Equivalents At Carrying Value	3	5	7	6	2	5	11	15	12	18	23	24
Supplies	-	-	0	0	0	1	1	1	2	1	1	-
Assets Current
Assets Current	4	5	7	7	4	7	13	17	14	19	25	26
Other Assets Current	0	0	0	1	3	0	1	1	1	1	1	1
Insurance Settlements Receivable Current	0	-	-	-	-	-	-	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense Noncurrent	-	-	0	0	0	1	1	2	1	1	1	-
Other Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	-	1
Deposits Assets Noncurrent	-	-	0	0	0	2	2	4	3	4	4	4
Deferred Finance Costs Noncurrent Net	-	-	0	0	0	0	-0	0	0	0	0	-
Assets	4	5	7	7	5	11	17	22	19	25	30	31
Liabilities And Stockhold…
Accounts Payable Current	0	1	2	4	4	1	1	0	1	1	1	1
Liabilities Current
Liabilities Current	0	1	2	7	8	2	3	2	2	2	2	2
Employee Related Liabilities Current	0	0	0	0	0	0	1	0	0	0	1	0
Accrued Liabilities Current	0	0	0	3	3	1	1	1	1	1	0	1
Long Term Debt	-	-	0	0	0	7	7	7	5	4	4	-
Warrants And Rights Outstanding	-	-	0	0	0	0	1	2	1	1	2	3
Liabilities	-	-	2	7	8	10	11	11	7	8	8	-
Preferred Stock Value	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	-	-	121	-	-	-	102	-	-	-	96	-
Stockholders Equity	3	4	5	-1	-3	0	6	12	12	17	22	26
Additional Paid In Capital Common Stock	121	121	-	115	103	103	-	102	97	96	-	96
Retained Earnings Accumulated Deficit	-118	-117	-116	-116	-106	-102	-96	-90	-85	-80	-74	-69
Liabilities And Stockholders Equity	4	5	7	7	5	11	17	22	19	25	30	31
Preferred Stock Dividend Rate Percentage	-	-	-	0	-	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	-	-	-	1	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	50	50	50	50	25	25	50	249	249	249	25	149
Common Stock Shares Issued	42	42	42	24	4	3	3	3	2	2	2	2
Shares Outstanding	42	42	42	24	4	3	3	3	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No price variance data available.

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Liquidity Ratios
Current Ratio	9.53	3.46	2.97	0.92	0.57	3.31	4.14	9.79	8.76	8.56	10.82	12.85
Quick Ratio	9.53	3.46	2.97	0.92	0.57	3.31	4.14	9.79	8.76	8.56	10.82	12.85
Working Capital	3.43M	3.67M	4.65M	-582.97K	-3.32M	4.98M	10.18M	15.23M	12.74M	17.18M	22.29M	23.76M
Leverage & Debt
Debt to Equity	0.12	0.41	0.51	-13.95	-2.64	20.95	1.75	0.91	0.62	0.49	0.38	0.08
Interest Coverage TTM	-	-38.83	-23.96	-21.48	-17.97	-15.84	-18.38	-21.57	-29.89	-45.77	-115.85	-
Debt Ratio	0.10	0.29	0.34	1.08	1.61	0.95	0.64	0.48	0.38	0.33	0.28	0.06
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01
Per Share Metrics
Free Cash Flow Per Share TTM	-0.26	-0.29	-0.40	-0.65	-5.12	-5.97	-5.77	-6.37	-10.06	-9.38	-8.51	-6.87
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	-2,414.63%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	3,369.33%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-	-150.00%
Net Income Growth (1Y)	-57.19%	-42.90%	-19.94%	8.81%	10.06%	31.65%	72.67%	103.51%	123.06%	122.49%	36.40%	41.70%
EPS Growth (1Y)	-96.37%	-95.30%	-93.42%	-84.24%	-27.65%	-12.47%	13.16%	33.38%	115.56%	118.92%	-3.93%	-4.47%
Calculated Values
Free Cash Flow TTM	-10.93M	-12.20M	-16.67M	-15.48M	-18.19M	-20.58M	-19.87M	-21.94M	-23.49M	-21.51M	-19.21M	-15.50M
Net Debt	-2.85M	-5.03M	-6.63M	-6.01M	-1.81M	2.06M	-4.49M	-8.77M	-7.27M	-13.12M	-18.47M	-24.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2015-11-30Purchase

Owner: Gengos, Andrew

Title: President and CEO

Shares: 10,000

Price/Share: $0.44

Value: $4,400.00

Shares Owned: 47,000

Relationship: Director,Officer

Ownership: Indirect

2015-02-18Purchase

Owner: Fractor, David

Title: VP of Finance

Shares: 16,667

Price/Share: $0.60

Value: $10,000.20

Shares Owned: 41,667

Relationship: Officer

Ownership: Direct

2015-02-18Purchase

Owner: Gengos, Andrew

Title: President and CEO

Shares: 41,333

Price/Share: $0.60

Value: $24,799.80

Shares Owned: 78,333

Relationship: Director,Officer

Ownership: Direct

2015-02-18Purchase

Owner: Gringeri, Anthony

Title: Senior VP Strategic Resources

Shares: 30,000

Price/Share: $0.60

Value: $18,000.00

Shares Owned: 66,000

Relationship: Officer

Ownership: Direct

2014-08-21Purchase

Owner: Gringeri, Anthony

Title: Senior VP Strategic Resources

Shares: 11,000

Price/Share: $0.91

Value: $10,010.00

Shares Owned: 36,000

Relationship: Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2015-11-30	Gengos, Andrew	Director,Officer	President and CEO	Indirect	Purchase	10,000	0.44	$4,400.00	47,000	4
2015-02-18	Fractor, David	Officer	VP of Finance	Direct	Purchase	16,667	0.60	$10,000.20	41,667	4
2015-02-18	Gengos, Andrew	Director,Officer	President and CEO	Direct	Purchase	41,333	0.60	$24,799.80	78,333	4
2015-02-18	Gringeri, Anthony	Officer	Senior VP Strategic Resources	Direct	Purchase	30,000	0.60	$18,000.00	66,000	4
2014-08-21	Gringeri, Anthony	Officer	Senior VP Strategic Resources	Indirect	Purchase	11,000	0.91	$10,010.00	36,000	4
2014-08-14	Gengos, Andrew	Director,Officer	President and CEO	Direct	Purchase	10,000	0.90	$9,000.00	37,000	4
2013-12-23	Gringeri, Anthony	Officer	Senior VP Strategic Resources	Indirect	Purchase	25,000	-	-	25,000	4
2013-12-20	Titus, Gary	Director	-	Direct	Purchase	18,000	0.78	$14,040.00	18,000	4
2013-12-18	Gengos, Andrew	Director,Officer	President and CEO	Direct	Purchase	27,000	0.72	$19,440.00	27,000	4
2013-11-26	Cowell, Richard	Director	-	Direct	Sale	28,000	3.86	$108,080.00	10,000	4
2013-10-21	Yu, John S	Director,Officer	Secretary	Indirect	Sale	36,006	2.92	$105,137.52	0	4
2013-10-18	Yu, John S	Director,Officer	Secretary	Indirect	Sale	32,613	2.85	$92,947.05	0	4
2013-08-29	Bender, James G.	Officer	VP, Product Development & Mfg.	Direct	Sale	900	3.00	$2,700.00	100	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2018-09-30

4.61%

Inst. Shares: 1,930,912

Shares Outstanding: 41,913,256

2018-06-30

3.85%

Inst. Shares: 1,614,535

Shares Outstanding: 41,913,256

2018-03-31

5.72%

Inst. Shares: 2,397,180

Shares Outstanding: 41,913,256

2017-12-31

2.21%

Inst. Shares: 927,355

Shares Outstanding: 41,913,256

2017-09-30

3.79%

Inst. Shares: 901,480

Shares Outstanding: 23,788,510

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2018-09-30	1,930,912	41,913,256	4.61%
2018-06-30	1,614,535	41,913,256	3.85%
2018-03-31	2,397,180	41,913,256	5.72%
2017-12-31	927,355	41,913,256	2.21%
2017-09-30	901,480	23,788,510	3.79%
2017-06-30	258,311	3,551,575	7.27%
2017-03-31	324,362	3,449,075	9.40%
2016-12-31	331,373	3,444,859	9.62%
2016-09-30	301,189	3,444,895	8.74%
2016-06-30	298,729	2,334,895	12.79%
2016-03-31	296,647	2,293,195	12.94%
2015-12-31	238,785	2,257,718	10.58%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

EOM Pharmaceutical Holdings, Inc. (IMUC) — SEC Financial Statements & Analysis

EOM Pharmaceutical Holdings, Inc. (IMUC) is a pharmaceutical preparations company, incorporated in DE. EOM Pharmaceutical Holdings, Inc. trades on OTC as: IMUC. Based on its latest SEC filing (Form 10-Q, period ending 2018-06-30), EOM Pharmaceutical Holdings, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.12x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.12x

Data as of 2018-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is EOM Pharmaceutical Holdings, Inc. in?

EOM Pharmaceutical Holdings, Inc. (IMUC) operates in the Pharmaceutical Preparations industry.

What exchange does IMUC trade on?

EOM Pharmaceutical Holdings, Inc. (IMUC) trades on the OTC.

Where is EOM Pharmaceutical Holdings, Inc. incorporated?

EOM Pharmaceutical Holdings, Inc. is incorporated in DE.